Regenoss

Flexible Bone Substitute

Regenoss

Bioceramic and collagen: synergenic power

RegenOss represents an innovative concept in bone grafting. It is a collagen-hydroxyapatite composite biomaterial designed at macro- and micro-scale to promote bone regeneration.

RegenOss is available in patches and strips that can perfectly fit the anatomic curvature of the graft site. During surgery, this osteostimulative and biodegradable scaffold can be easily adapted to the dimension and shape of the defect, saving time and improving placement.

Regenoss

TECHNICAL SPECIFICATIONS

Nano structure A
Nano structure B
Nano structure C
Nano structure D

Biomimetic structure: as modelled in nature

RegenOss is a biomimetic scaffold whose structure and chemical composition make it similar to human bone.

RegenOss is manufactured through a patented process, which mimics the natural neoossification process and consists in the nucleation of magnesium-hydroxyapatite crystals on collagen fibres.

New bone A
New bone B
New bone C
New bone D

Replaced by new bone

RegenOss is highly hydrophilic and can be adapted to the lodging to create an anatomic continuity; it can quickly absorb the biological fluids, molecules and cells promoting bone formation. Biomimetic porous structure guides and coordinates cells attachment and proliferation. 

While serving as a scaffold to guide effective bone regeneration, RegenOss is resorbed by enzymes and cellular action over a period of 6-12 months.

RegenOss

INDICATIONS

Clinical applications

RegenOss is designed for use in a broad range of procedures, such as:

Scheletro RegenOss Flexible bone substitute
Combined A
Combined B
Combined D

RegenOss may be combined with autologous bone, physiological fluids, antibiotics and platelet concentrate (PRP).

RegenOss is intended to be used to fill bone gaps and voids.
It cannot replace standard procedures for the treatment of bone defects.
Moreover, it must be used with appropriate mechanical stabilisation and internal fixation devices.

RegenOss

SHAPES AND SIZES

RegenOss Ortho is available with the following codes:

RegenOss Ortho
RegenOss Ortho
Code Description Quantity
01600816 3,5 x 3,5 x 0,5 cm 1
01600824 6,5 x 6,5 x 0,5 cm 1

RegenOss Spine is available with the following codes:

RegenOss Spine
RegenOss Spine
Code Description Quantity
01600821 2,5 × 7,5 x 0,5 cm 1
Explore resources by product

CLINICAL STUDIES

Clinical paper
02/2025 - M. Peters et al. Comparison of bone ingrowth and clinical outcome of a collagen-hydroxyapatite bone graft substitute with autologous bone graft in Posterior Lumbar Interbody Fusion. » Learn more Download Download PDF
Product: Regenoss
Keyword: Performance Safety
Clinical paper
08/2024 - G. Calvosa et al. Lumbar Posterolateral Fusion using a collagen-hydroxyapatite biomimetic bone substitute which autologous bone graft: a prospective observational, non randomized, single arm study. » Learn more
Product: Regenoss
Keyword: Performance Safety
Clinical paper
11/2022 - G. Barbanti Brodano et al. Critical evaluation of the scientific literature concerning bone graft alternatives in spinal surgery and focus on bioceramics. » Learn more
Product: Engipore
Keyword: Safety
Clinical paper
10/2022 - P. Cimatti et al. An Observational Prospective Clinical Study for the Evaluation of a Collagen-Hydroxyapatite Composite Scaffold in Hip Revision Surgery. » Learn more Download Download PDF
Product: Regenoss
Keyword: Performance Safety
Clinical paper
07/2020 - G. Gioia et al. Histological assessment of new bone formation with biomimetic scaffold in posterolateral lumbar spine. » Learn more Download Download PDF
Product: Regenoss
Keyword: Performance
Clinical paper
01/2020 - A. Barbanera et al. Clinical performance of a collagen-based hydroxyapatite bone graft substitute in procedures of spinal arthrodesis. » Learn more
Product: Regenoss
Keyword: Performance Safety
Pre-clinical paper
05/2019 - M. Ding et al. Collagen-hydroxyapatite composite substitute and bone marrow nuclear cells on posterolateral spine fusion in sheep. » Learn more
Product: Regenoss
Keyword: Osteointegration
Clinical paper
07/2017 - P. Giorgi et al. A new bioinspired collagen-hydroxyapatite bone graft substitute in adult scoliosis surgery: results at 3 years follow-up. » Learn more Download Download PDF
Product: Regenoss
Keyword: Performance Safety
Clinical paper
05/2016 - B. Grigolo et al. Histologically demonstrated posterolateral spine fusion using a collagen-hydroxyapatite bone substitute in human: a case report.
Product: Regenoss
Keyword: Performance
Clinical paper
11/2015 - C.L. Romanò et al. Antibiotic-loaded RegenOss for the treatment of septic bone defects in vitro study and preclinical experience. » Learn more
Product: Regenoss
Keyword: Performance Safety

Access to the professional area of finceramica.it

Warning

The information contained in this section of the site is intended exclusively for healthcare professionals in accordance with art. 21 of Legislative Decree 24 February 1997, n. 46 as amended and the Guidelines of the Ministry of Health of 17 February 2010 and subsequent update of 18 March 2013.

To proceed click "Proceed" or "Go to home"

The system will remember your choice

Restricted Area for Medical and Healthcare Personnel

Welcome to MyFin

Log in to MyFin, our exclusive area for medical and healthcare personnel, and access confidential documents about our innovative products.

Not registered yet?

Are you a medical and healthcare professional?

Request access to MyFin

MyFin is Finceramica’s restricted area dedicated to medical and healthcare personnel, allowing access to confidential documents about our innovative products.

Already have a MyFin account?

Password Recovery

If you have forgotten your password, please enter your email address below. We will send you a secure link to reset your password.If you do not receive the email within a few minutes, please check your spam or junk folder. You may also request a new link if necessary.

Not registered yet?

Search within the portal

Enter the keyword you are looking for
Write to us